Phase II evaluation of AMSA in patients with metastatic lung cancer

W. C. Nichols, R. T. Eagan, S. Frytak, J. N. Ingle, E. T. Creagan, L. K. Kvols

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of AMSA in patients with metastatic lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science